EA024825B8 - Сокристалл тикагрелора с 3-гидрокси-2-нафтойной кислотой, способ его получения и применение - Google Patents

Сокристалл тикагрелора с 3-гидрокси-2-нафтойной кислотой, способ его получения и применение

Info

Publication number
EA024825B8
EA024825B8 EA201590112A EA201590112A EA024825B8 EA 024825 B8 EA024825 B8 EA 024825B8 EA 201590112 A EA201590112 A EA 201590112A EA 201590112 A EA201590112 A EA 201590112A EA 024825 B8 EA024825 B8 EA 024825B8
Authority
EA
Eurasian Patent Office
Prior art keywords
preparation
ticagrelor
hydroxy
naphthoic acid
cocrystal
Prior art date
Application number
EA201590112A
Other languages
English (en)
Other versions
EA024825B1 (ru
EA201590112A1 (ru
Inventor
Шармарке Мохамед
Людмила Гейтманкова
Лудек Ридван
Марцела Ткадлецова
Ондрей Даммер
Original Assignee
Зентива, К.С.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Зентива, К.С. filed Critical Зентива, К.С.
Publication of EA201590112A1 publication Critical patent/EA201590112A1/ru
Publication of EA024825B1 publication Critical patent/EA024825B1/ru
Publication of EA024825B8 publication Critical patent/EA024825B8/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Твердотельные структуры (1S,2S,3R,5S)-3-[7-[(1R,2S)-2-(3,4-дифторфенил)циклопропил]-5-(пропилтио)-3Н-[1,2,3]триазоло[4,5-d]пиримидин-3-ил]-5-(2-гидроксиэтокси)циклопентан-1,2-диола (тикагрелор) в виде стабильной сокристаллической формы с 3-гидрокси-2-нафтойной кислотой, способ их получения и применение для получения фармацевтической композиции.
EA201590112A 2012-06-29 2012-06-29 Сокристалл тикагрелора с 3-гидрокси-2-нафтойной кислотой, способ его получения и применение EA024825B8 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CZ2012/000059 WO2014000719A1 (en) 2012-06-29 2012-06-29 Novel pharmaceutical solid forms of (1s,2s,3r,5s)-3-[7-[(1r,2s)-2-(3,4difluorophenyl)cyclopropylamino]-5-(propylthio)-3h-[1,2,3]triazolo[4,5-d]pyrimidin-3yl]-5-(2-hydroxyethoxy)cyclopentane-l,2-diol

Publications (3)

Publication Number Publication Date
EA201590112A1 EA201590112A1 (ru) 2015-05-29
EA024825B1 EA024825B1 (ru) 2016-10-31
EA024825B8 true EA024825B8 (ru) 2016-12-30

Family

ID=46583808

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201590112A EA024825B8 (ru) 2012-06-29 2012-06-29 Сокристалл тикагрелора с 3-гидрокси-2-нафтойной кислотой, способ его получения и применение

Country Status (4)

Country Link
EP (1) EP2867235A1 (ru)
BR (1) BR112014032085A2 (ru)
EA (1) EA024825B8 (ru)
WO (1) WO2014000719A1 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015162630A1 (en) 2014-04-25 2015-10-29 Anlon Chemical Research Organization Novel processes for preparing triazolo [4,5-d]- pyrimidines, including ticagrelor, vianew intermediates and new route of synthesis.
WO2016116942A1 (en) 2015-01-20 2016-07-28 Anlon Chemical Research Organization Novel pharmaceutical compounds comprising ticagrelor with salts of aspirin
US10905691B2 (en) 2016-09-09 2021-02-02 Université de Liège Use of triazolo(4,5-d)pyrimidine derivatives for prevention and treatment of bacterial infection
DK3292867T3 (da) * 2016-09-09 2019-07-22 Univ Liege Ny brug af triazol(4,5-d)pyrimidinderivater til brug i forebyggelsen og behandlingen af bakteriel infektion
WO2018178997A1 (en) * 2017-03-31 2018-10-04 Natco Pharma Limited Novel crystalline form of ticagrelor

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000034283A1 (en) * 1998-12-04 2000-06-15 Astrazeneca Ab Novel triazolo(4,5-d)pyrimidine compounds
WO2001092262A1 (en) * 2000-06-02 2001-12-06 Astrazeneca Ab New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound
WO2011067571A1 (en) * 2009-12-03 2011-06-09 Astrazeneca Ab Co - crystals of a triazolo [4,5 - d] pyrimidine platelet aggregation inhibitor

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000034283A1 (en) * 1998-12-04 2000-06-15 Astrazeneca Ab Novel triazolo(4,5-d)pyrimidine compounds
WO2001092262A1 (en) * 2000-06-02 2001-12-06 Astrazeneca Ab New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound
WO2011067571A1 (en) * 2009-12-03 2011-06-09 Astrazeneca Ab Co - crystals of a triazolo [4,5 - d] pyrimidine platelet aggregation inhibitor

Also Published As

Publication number Publication date
EP2867235A1 (en) 2015-05-06
WO2014000719A1 (en) 2014-01-03
EA024825B1 (ru) 2016-10-31
BR112014032085A2 (pt) 2017-06-27
EA201590112A1 (ru) 2015-05-29

Similar Documents

Publication Publication Date Title
CL2013003647A1 (es) Compuestos derivados de pirrolo[2,3-d] pirimidina o pirrolo[2,3-b]piridina, inhibidores de la actividad de jak; composicion farmaceutica; utiles para el tratamiento de enfermedades autoinmunitarias, inflamatorias y de reabsorcion osea, cancer, trastornos mieloproliferativos o rechazo a trasplante de organos.
WO2012155066A3 (en) Spiro-oxindole mdm2 antagonists
CL2014001752A1 (es) Compuestos biciclicos sustituidos; composicion farmaceutica que los comprende; y uso en el tratamiento de enfermedades tales como cancer, alzheimer, sida, entre otras.
WO2012065022A3 (en) Spiro-oxindole mdm2 antagonists
WO2015042078A3 (en) Substituted aminopyrimidine compounds and methods of use
EA202090662A2 (ru) ПРОИЗВОДНЫЕ ПИРРОЛО[3,2-d]ПИРИМИДИНА ДЛЯ ЛЕЧЕНИЯ ВИРУСНЫХ ИНФЕКЦИЙ И ДРУГИХ ЗАБОЛЕВАНИЙ
CL2014000494A1 (es) Compuestos derivados de imidazo[1,2-a]piridina, como inhibidores de las quinasas pdgfr y/o c-kit; composicion farmaceutica que los comprende; y su uso para tratar una enfermedad asociada con mastocitos, una enfermedad respiratoria, una enfermedad metabolica, un trastorno autoinmune, una enfermedad dermatologica, entre otras.
EA024825B8 (ru) Сокристалл тикагрелора с 3-гидрокси-2-нафтойной кислотой, способ его получения и применение
PT2794611T (pt) Pirazolo[1,5-a]pirimidinas como agentes antivirais
CR20130617A (es) Derivados de piridin-2(1h)-ona útiles como medicamentos para el tratamiento de trastornos mieloproliferativos, rechazo de trasplantes, enfermedades mediadas por el sistema inmune y enfermedades inflamatorias
DOP2014000255A (es) Uracilos sustituidos bicíclicamente y uso de los mismos
EA201291310A1 (ru) Композиция ингибитора jak для местного применения
EA201590745A1 (ru) Твердая пероральная фармацевтическая композиция, содержащая тикагрелор
EA201892150A1 (ru) Распадающиеся в полости рта таблетки
CL2015001342A1 (es) Compuestos derivados de pirrolo[3,2-d]pirimidina; composicion farmaceutica y de vacuna que los comprende y el uso en el tratamiento de enfermedades alergicas y otras enfermedades inflamatorias, infecciosas y cancer.
BR112014001665A2 (pt) compostos de 2,3-di-hidroimidazo[1,2-c]pirimidin-5(1h)-ona utilizados como inibidores de lp-plaz
WO2013004995A8 (en) Pyrimidinone compounds and their use
EA201591379A1 (ru) Липопротеин-ассоциированные ингибиторы фосфолипазы a2 (lp-pla) на основе 2,3-дигидроимидазо[1,2-с]пиримидин-5(1h)-онов
NI201500152A (es) FORMULACIONES FARMACÉUTICAS, PROCESO, FORMAS SÓLIDAS Y MÉTODOS DE USO RELACIONADOS CON 1 - ETIL - 7- (2 - METIL - 6 - (1H - 1, 2, 4 - TRIAZOL - 3 - IL) PIRIDIN - 3 - IL) - 3, 4 - DIHIDROPIRAZINO [2, 3-b] PIRAZIN - 2(1H) - ONA.
PH12019502111A1 (en) Subcutaneous administration of a p2y12 receptor antagonist
HK1198441A1 (en) Pyrazolo[3,4-d]pyrimidine compounds, their preparation and use as sigma ligands [34-d]
MY166556A (en) Pharmaceutical formulation for topical administration comprising b220
NZ705994A (en) Process for preparing pemetrexed di potassium and its hydrates
IL231934A (en) 4-Amino-3-Phenylamino-6-Phenylpyrazolo (4,3-d) Pyramidine derivatives, their production and use as active antiviral substances
WO2013054364A3 (en) Novel salts of sitagliptin, process for the preparation and pharmaceutical composition thereof

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM RU